THERAPEUTICS

 

DISCOVERY PROGRAMS

     viDA is a research based biotechnology company using its expertise, based on newly identified pathological roles for a family of granule secreted enzymes called Granzymes, to discover and develop novel, first-in-class drugs for the treatment of inflammatory and age-related conditions of the skin, respiratory, musculoskeletal, cardiovascular, and neurological systems.

INITIAL DEVELOPMENT PROGRAM
GRANZYMES
NEWS
viDA THERAPEUTICS